Axxcess Wealth Management LLC Sells 10,095 Shares of Colgate-Palmolive (NYSE:CL)

Axxcess Wealth Management LLC lowered its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 20.7% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 38,669 shares of the company's stock after selling 10,095 shares during the quarter. Axxcess Wealth Management LLC's holdings in Colgate-Palmolive were worth $4,014,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of CL. TD Asset Management Inc raised its holdings in Colgate-Palmolive by 2.4% in the 1st quarter. TD Asset Management Inc now owns 1,154,566 shares of the company's stock valued at $103,969,000 after acquiring an additional 26,987 shares in the last quarter. Empowered Funds LLC raised its stake in Colgate-Palmolive by 277.3% in the first quarter. Empowered Funds LLC now owns 33,082 shares of the company's stock valued at $2,979,000 after purchasing an additional 24,314 shares in the last quarter. M&G Plc bought a new stake in Colgate-Palmolive during the first quarter worth about $3,812,000. Sei Investments Co. grew its stake in Colgate-Palmolive by 41.5% during the first quarter. Sei Investments Co. now owns 598,639 shares of the company's stock worth $53,901,000 after buying an additional 175,445 shares in the last quarter. Finally, Gordian Advisors LLC acquired a new stake in Colgate-Palmolive during the third quarter worth about $602,000. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Trading Down 0.6 %

Shares of CL traded down $0.57 during trading hours on Monday, hitting $92.00. 3,539,002 shares of the stock were exchanged, compared to its average volume of 4,374,662. Colgate-Palmolive has a fifty-two week low of $75.17 and a fifty-two week high of $109.30. The business has a 50-day moving average of $100.91 and a 200-day moving average of $98.50. The firm has a market capitalization of $75.17 billion, a P/E ratio of 26.35, a price-to-earnings-growth ratio of 3.31 and a beta of 0.42. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 2.17%. Colgate-Palmolive's dividend payout ratio is currently 57.31%.

Insiders Place Their Bets

In other news, Director Martina Hundmejean sold 2,313 shares of the firm's stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now owns 11,755 shares of the company's stock, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. In other news, Director Martina Hundmejean sold 2,313 shares of the firm's stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CFO Stanley J. Sutula III sold 45,410 shares of the company's stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on CL shares. Redburn Atlantic upgraded shares of Colgate-Palmolive to a "hold" rating in a research report on Thursday, August 1st. Stifel Nicolaus downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating and reduced their target price for the company from $105.00 to $101.00 in a report on Monday, October 28th. TD Cowen decreased their price target on Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Monday, October 28th. HSBC reissued a "hold" rating on shares of Colgate-Palmolive in a report on Friday, July 26th. Finally, Morgan Stanley raised their price objective on Colgate-Palmolive from $103.00 to $111.00 and gave the company an "overweight" rating in a research note on Monday, July 29th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $105.11.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.